Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Virendra Bhandari, Saloni Singhal, Ashar Lodi & Amresh Kumar. (2023) Survival and analysis of patients with various central nervous tumors who received post-operative radiation therapy: A retrospective study. IP Indian Journal of Neurosciences 9:4, pages 209-213.
Crossref
Crossref
Saloni Singhal, Amresh Kumar, Neha Singh Rajput, Ashar Iqbal Lodi & Virendra Bhandari. (2023) Assessment of progression-free survival and overall survival in patients of glioblastoma post-radiation therapy. International Journal of Neurooncology 6:1, pages 10-13.
Crossref
Crossref
Brittany Dewdney, Lauren Ursich, Emily V. Fletcher & Terrance G. Johns. (2022) Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?. Cancers 14:23, pages 5932.
Crossref
Crossref
Sen Yang, Zhan‐Zhao Fu, Yan‐qiu Zhang, Bao‐hong Fu & Lixin Dong. (2021) The G to A transformation of rs4702 polymorphism in 3’UTR of FURIN reduced the risk of radiotherapy‐induced cognitive impairment in glioma patients. Journal of Cellular and Molecular Medicine 26:3, pages 684-692.
Crossref
Crossref
Nidhi Gupta, Shankar Prinja, Vijay Patil & Pankaj Bahuguna. (2021) Cost-Effectiveness of Temozolamide for Treatment of Glioblastoma Multiforme in India. JCO Global Oncology:7, pages 108-117.
Crossref
Crossref
Venkatesh S. Madhugiri, Aliasgar V. Moiyadi, Prakash Shetty, Tejpal Gupta, Sridhar Epari, Rakesh Jalali, Venkatesan Subeikshanan, Akshat Dutt, Gopalakrishnan M. Sasidharan, V.R. Roopesh Kumar, C.V. Shankar Ganesh, Andi Sadayandi Ramesh & A. Sathia Prabhu. (2021) Analysis of Factors Associated with Long-Term Survival in Patients with Glioblastoma. World Neurosurgery 149, pages e758-e765.
Crossref
Crossref
Almos Klekner, Judit Tóth, József Virga, Tibor Hortobágyi, Ádám Dér, Csaba Szemcsák, Judit Reményi-Puskár & László Bognár. (2019) Influence of Oncotherapy and Clinical Parameters on Survival of Glioblastoma Patients: A Single Center Experience. Neurology India 67:4, pages 1066.
Crossref
Crossref
Giorgio M. Callovini, Stefano Telera, Shahram Sherkat, Isabella Sperduti, Tommaso Callovini & Carmine M. Carapella. (2018) How is stereotactic brain biopsy evolving? A multicentric analysis of a series of 421 cases treated in Rome over the last sixteen years. Clinical Neurology and Neurosurgery 174, pages 101-107.
Crossref
Crossref
Tejpal Gupta, Sridhar Epari, Aliasgar Moiyadi, Prakash Shetty, JayantSastri Goda, Rahul Krishnatry, Girish Chinnaswamy, Tushar Vora, Hari Menon, Vijay Patil, Ayushi Sahay, Nazia Bano & Rakesh Jalali. (2017) Demographic profile, clinicopathological spectrum, and treatment outcomes of primary central nervous system tumors: Retrospective audit from an academic neuro-oncology unit. Indian Journal of Cancer 54:4, pages 594.
Crossref
Crossref
M Ghosh, S Shubham, K Mandal, V Trivedi, R Chauhan & S Naseera. (2017) Survival and prognostic factors for glioblastoma multiforme: Retrospective single-institutional study. Indian Journal of Cancer 54:1, pages 362.
Crossref
Crossref
Rakesh JalaliAnupam RishiJayant S. GodaEpari SridharMamta GuravPravin SharmaAliasgar MoiyadiPrakash ShettyTejpal Gupta. (2016) Clinical outcome and molecular characterization of pediatric glioblastoma treated with postoperative radiotherapy with concurrent and adjuvant temozolomide: a single institutional study of 66 children. Neuro-Oncology Practice 3:1, pages 39-47.
Crossref
Crossref
Jayant S. Goda, Shirley Lewis, Aditi Agarwal, Sridhar Epari, Shraddha Churi, A. Padmavati, Tejpal Gupta, Prakash Shetty, Aliasgar Moiyadi & Rakesh Jalali. (2015) Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma?. Clinical Neurology and Neurosurgery 135, pages 46-53.
Crossref
Crossref
K. Han, M. Ren, W. Wick, L. Abrey, A. Das, J. Jin & D. A. Reardon. (2013) Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials. Neuro-Oncology 16:5, pages 696-706.
Crossref
Crossref
Abdolazim Sedighi Pashaki, Ehsan Akbari Hamed, Kamal Mohamadian, Mohammad Abassi, Afsane Maddah Safaei & Tayebe Torkaman. (2014) Efficacy of High Dose Radiotherapy in Post-operative Treatment of Glioblastoma Multiform - A Single Institution Report. Asian Pacific Journal of Cancer Prevention 15:6, pages 2793-2796.
Crossref
Crossref
Tejpal Gupta, Sarthak Mohanty, Aliasgar Moiyadi & Rakesh Jalali. (2013) Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: A clinical audit. Clinical Neurology and Neurosurgery 115:9, pages 1814-1819.
Crossref
Crossref
Jennifer Ho, John Ondos, Holly Ning, Sharon Smith, Teri Kreisl, Fabio Iwamoto, Joohee Sul, Lyndon Kim, Kate McNeil, Andra Krauze, Uma Shankavaram, Howard A. Fine & Kevin Camphausen. (2013) Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience. PLoS ONE 8:8, pages e70745.
Crossref
Crossref
Zuzana Tatar, Emilie Thivat, Eloise Planchat, Pierre Gimbergues, Emilie Gadea, Catherine Abrial & Xavier Durando. (2013) Temozolomide and unusual indications: Review of literature. Cancer Treatment Reviews 39:2, pages 125-135.
Crossref
Crossref
Nilgun Ozbek Okumus, Bilge Gursel, Deniz Meydan, Ozge Ozdemir, Eylem Odabası & Guzin Gonullu. (2012) Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients. Annals of Saudi Medicine 32:3, pages 250-255.
Crossref
Crossref
Sadhak Sengupta, Jaclyn Marrinan, Caroline Frishman & Prakash Sampath. (2012) Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy. Clinical and Developmental Immunology 2012, pages 1-7.
Crossref
Crossref
Mallavarapu R. Srividya, Balaram Thota, Bangalore C. Shailaja, Arimappamagan Arivazhagan, Kandavel Thennarasu, Bangalore A. Chandramouli, Alangar S. Hegde & Vani Santosh. (2010)
Homozygous 10q23/
PTEN
deletion and its impact on outcome in glioblastoma: A prospective translational study on a uniformly treated cohort of adult patients
. Neuropathology 31:4, pages 376-383.
Crossref
Crossref
K. J. Cohen, I. F. Pollack, T. Zhou, A. Buxton, E. J. Holmes, P. C. Burger, D. J. Brat, M. K. Rosenblum, R. L. Hamilton, R. S. Lavey & R. L. Heideman. (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro-Oncology 13:3, pages 317-323.
Crossref
Crossref
Rakesh Jalali, Nirmal Raut, Brijesh Arora, Tejpal Gupta, Debnarayan Dutta, Anusheel Munshi, Rajiv Sarin & Purna Kurkure. (2010) Prospective Evaluation of Radiotherapy With Concurrent and Adjuvant Temozolomide in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma. International Journal of Radiation Oncology*Biology*Physics 77:1, pages 113-118.
Crossref
Crossref
C. Nieder, M.P. Mehta & R. Jalali. (2009) Combined Radio- and Chemotherapy of Brain Tumours in Adult Patients. Clinical Oncology 21:7, pages 515-524.
Crossref
Crossref
Rakesh Jalali. (2008) Radiochemotherapy in Patients With Primary Glioblastoma Comparing Two Temozolomide Dose Regimens: Is the Survival Really so Impressive?: In Regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999–1005). International Journal of Radiation Oncology*Biology*Physics 72:5, pages 1622.
Crossref
Crossref
Kaisorn L. Chaichana, Matthew J. McGirt, James Frazier, Frank Attenello, Hugo Guerrero-Cazares & Alfredo Quinones-Hinojosa. (2008) Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. Journal of Neuro-Oncology 89:2, pages 219-224.
Crossref
Crossref
Tariq Parvez. (2008) Present Trend in the Primary Treatment of Aggressive Malignant Glioma: Glioblastoma Multiforme. Technology in Cancer Research & Treatment 7:3, pages 241-248.
Crossref
Crossref